These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Differentiation of pluripotent stem cells into male germ cells: An update]. Wang SY; Cui YG; Qin LJ Zhonghua Nan Ke Xue; 2017 May; 23(5):468-472. PubMed ID: 29717842 [TBL] [Abstract][Full Text] [Related]
26. Editorial: Our top 10 developments in stem cell biology over the last 30 years. Armstrong L; Lako M; Buckley N; Lappin TR; Murphy MJ; Nolta JA; Pittenger M; Stojkovic M Stem Cells; 2012 Jan; 30(1):2-9. PubMed ID: 22162299 [TBL] [Abstract][Full Text] [Related]
28. 3,2'-Dihydroxyflavone-Treated Pluripotent Stem Cells Show Enhanced Proliferation, Pluripotency Marker Expression, and Neuroprotective Properties. Han D; Kim HJ; Choi HY; Kim B; Yang G; Han J; Dayem AA; Lee HR; Kim JH; Lee KM; Jeong KS; Do SH; Cho SG Cell Transplant; 2015; 24(8):1511-32. PubMed ID: 25198120 [TBL] [Abstract][Full Text] [Related]
29. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Shiraki N; Shiraki Y; Tsuyama T; Obata F; Miura M; Nagae G; Aburatani H; Kume K; Endo F; Kume S Cell Metab; 2014 May; 19(5):780-94. PubMed ID: 24746804 [TBL] [Abstract][Full Text] [Related]
30. Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs. Kim E; Hyun SH Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626414 [TBL] [Abstract][Full Text] [Related]
31. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. Qi SD; Smith PD; Choong PF ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845 [TBL] [Abstract][Full Text] [Related]
32. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology. Galach M; Utikal J Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557 [TBL] [Abstract][Full Text] [Related]
33. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming. Kang L; Kou Z; Zhang Y; Gao S J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705 [TBL] [Abstract][Full Text] [Related]
34. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
35. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. Qi SD; Smith PD; Choong PF ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037 [TBL] [Abstract][Full Text] [Related]
36. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. Menon S; Shailendra S; Renda A; Longaker M; Quarto N Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822 [TBL] [Abstract][Full Text] [Related]
37. The state of the art for pluripotent stem cells derivation in domestic ungulates. Malaver-Ortega LF; Sumer H; Liu J; Verma PJ Theriogenology; 2012 Nov; 78(8):1749-62. PubMed ID: 22578625 [TBL] [Abstract][Full Text] [Related]
38. Biological Significance of the Suppression of Oxidative Phosphorylation in Induced Pluripotent Stem Cells. Zhang C; Skamagki M; Liu Z; Ananthanarayanan A; Zhao R; Li H; Kim K Cell Rep; 2017 Nov; 21(8):2058-2065. PubMed ID: 29166598 [TBL] [Abstract][Full Text] [Related]
39. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling. Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671 [TBL] [Abstract][Full Text] [Related]
40. Comparative transcriptomic analysis identifies reprogramming and differentiation genes differentially expressed in UiPSCs and ESCs. Shi L; Cui Y; Zhou X; Luan J; Wang L; Han J Biosci Trends; 2017 Jul; 11(3):355-359. PubMed ID: 28529265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]